StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NOL.AX$1.26+0.80%
Fair $1.26+0.0%

NOL.AX

NobleOak Life Limited

Financial Services / Insurance - LifeASX

$1.26

+0.01 (+0.80%)

Fairly Valued+0.0%Fair Value $1.26Fund rank 36/100 · Data gapFallback financials|
SA 33/D
F-Score: 2/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 27.0/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

33/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

12/100

SEC 0%

Latest source: unknownPeriods: 3Warnings: 0unknown: 3
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified.
Thesis & Journal · NOL.AXLocal privado en este navegador · NobleOak Life Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$117M

P/E

25.2x

↑

EV/EBITDA

N/A

•

ROE

13.0%

↑

Gross Margin

N/A

•

Debt/Equity

0.07

↓
52-Week Range$1
$1$2

TradingView lightweight chart

NOL.AX price, volumen y niveles de valoración

Último $1.260Periodo -35.4%
Fair value: $1.260

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2024 · 2 años de histórico normalizado

Revenue CAGR

-21.8%

FCF CAGR

+36.9%

FCF margin

39.9%

FCF / Net income

4.74x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $110.3M · net income $9.3M · FCF $44.0M

2022-FY → 2024-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

8.4%+7.5% pts

FCF margin

39.9%+26.9% pts
MetricTTM
2024
2023
2022
Income Statement
Revenue$110.3M$110.3M$194.1M$180.6M
Net Income$9.3M$9.3M$8.0M$1.7M
EPS0.100.100.090.02
Net Margin8.4%8.4%4.1%0.9%
Balance Sheet
Debt/Equity0.070.070.050.00
Current Ratio2.152.15——
Cash Flow
Free Cash Flow$44.0M$44.0M$129.7M$23.5M
Returns
ROE13.0%13.0%6.7%1.5%
Valuation
P/E25.2025.2018.61109.74
P/B1.561.561.241.66
Growth & Yield
Revenue Growth-43.2%-43.2%7.5%—
EPS Growth15.5%15.5%365.6%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

2.1%

fácil

EPS terminal req.

$0.11

Spread vs growth

13.4%

5Y implied EPS CAGR

5.2%

razonable

EPS terminal req.

$0.14

Spread vs growth

10.3%

10Y implied EPS CAGR

7.6%

razonable

EPS terminal req.

$0.22

Spread vs growth

7.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -8.4%

Total return

-8.4%

Start / end P/E

15.1x → 12.0x

EPS bridge

0.09 → 0.10

Residual

-3.2%

EPS growth+15.5%
Multiple rerating-20.7%
Dividend+0.0%
Residual / FX / buybacks / cross-term-3.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.